Assessment of liver fibrosis and cirrhosis is crucial for the management of patients with chronic hepatitis B. The presence of at least moderate liver fibrosis is an important indication for antiviral ...

With several drugs in use that inhibit the hepatitis B virus polymerases (nucleos(t)ide analogues (or NUCs)), some argue that new direct-acting antiviral drugs, and new NUCs in particular ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

New Delhi: Pharmaceutical major Dr Reddy's has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to manufacture and market ...

Background: The immune response and safety of inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines among patients with chronic hepatitis B (CHB), especially ... Cirrhotic ...

Chronic hepatitis D (CHD ... had to be terminated due to hepatic flares. Monoclonal antibodies against HBsAg as a monotherapy or combined with small interference RNA targeting hepatitis B virus ...

Hepatitis B virus (HBV)-specific T cells are exhausted and impaired in patients with chronic HBV infection ... specific T cell function were analysed as previously described (for antibodies see online ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD). Brelovitug is a fully human ...

Study: AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in ... or HBV core antibody (anti-HBc). The most common cause of HBVr is prolonged ...

Estimates suggest that about 240 million people around the world have chronic hepatitis B. Up to 1.89 million people in the United States have a chronic HBV infection. Adults typically receive the ...

It should include a "triple" panel of HBsAg, antibodies to HBV surface Ag ... Certain groups with chronic hepatitis B or prior exposure to hepatitis B are at increased risk of HBVr, particularly ...